Home » Topics » Regulatory

Regulatory
RSS

FDA grants accelerated approval to Imfinzi for previously treated bladder cancer

May 2, 2017

FDA approves Stivarga for second-line treatment of hepatocellular carcinoma

April 28, 2017

FDA approves Brineura to treat CLN2 disease

April 28, 2017

FDA grants accelerated approval to Tecentriq for bladder cancer not treatable with cisplatin

April 18, 2017

FDA grants approval for Ingrezza capsules for adults with tardive dyskinesia

April 12, 2017

FDA approves Austedo to treat chorea associated with Huntington's disease

April 4, 2017

European Commission approves Tafinlar with Mekinist for BRAF V600-positive NSCLC

April 3, 2017

Munipharma's Mundesine capsules approved in Japan

April 3, 2017

FDA approves Dupixent for moderate to severe atopic dermatitis

March 29, 2017

FDA approves Ocrevus for relapsing and primary progressive forms of MS

March 29, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...